Showing results (191-200 of 239) with videos related to
Sort By:
Pageof 24
Cancer Research|January 7, 2006
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendationsRalph H Hruban, N Volkan Adsay, Jorge Albores-Saavedra, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2015
Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes MellitusClaire Jenkinson, Victoria L Elliott, Anthony Evans, et al.Nature Communications|January 29, 2015
ADAM8 as a drug target in pancreatic cancerUwe Schlomann, Garrit Koller, Catharina Conrad, et al.Cancer Cell|January 7, 2004
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouseSunil R Hingorani, Emanuel F Petricoin, Anirban Maitra, et al.Gut|April 3, 2012
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancerMichael A Jacobetz, Derek S Chan, Albrecht Neesse, et al.JCI Insight|September 29, 2020
KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in miceJasmine C Wong, Pedro A Perez-Mancera, Tannie Q Huang, et al.Nature Communications|December 3, 2024
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancerLisa Veghini, Davide Pasini, Rui Fang, et al.Annals of Surgery|July 14, 2020
Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic CancerToni T Seppälä, Jacquelyn W Zimmerman, Elisabetta Sereni, et al.Nature Communications|October 9, 2025
WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2Jordan C J Wilson, JiaYi Zhu, Vanesa Vinciauskaite, et al.Cell|January 6, 2015
Organoid models of human and mouse ductal pancreatic cancerSylvia F Boj, Chang-Il Hwang, Lindsey A Baker, et al.Pageof 24